4//SEC Filing
Mack Gene 4
Accession 0001493152-24-013983
CIK 0001819411other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 7:44 PM ET
Size
5.5 KB
Accession
0001493152-24-013983
Insider Transaction Report
Form 4
Mack Gene
DirectorCEO, President
Transactions
- Award
Employee Stock Option (right to buy)
2024-04-08+200,000→ 200,000 totalExercise: $3.56Exp: 2034-04-08→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest 25% on April 8, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001737979
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 7:44 PM ET
- Size
- 5.5 KB